InRAD Observational Study
Recruiting
Observational Study
Alzheimer's Disease(AD)
Mild Cognitive Impairment (MCI)
Subjective Cognitive Decline (SCD)
Non-Alzheimer Degenerative Dementia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 50,000 (estimated)
- Sponsor
- Stichting International Registry for Alzheimer's Disease and other Dementias Foundation · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers.
The InRAD Registry Observational Study has several aims:
* To collect medical information for many years from a large group of people with Alzheimer…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Be undergoing diagnostic work-up for Alzheimer's disease (AD), OR
* Have a confirmed diagnosis of AD (whether currently treated with an AD-specific treatment, or untreated),
* Be attending an InRAD Center,
* Have provided informed consent for long-term follow-up
Exclusion Cri…
Contacts